Facial Volume Loss Melbourne

The phrase facial volume loss describes what happens visibly. The clinical reality is more layered. The face is composed of bone, deep fat pads, superficial fat compartments, retaining ligaments, expressive musculature, dermis and epidermis, and ageing alters all of these on overlapping but distinct timelines. Treating the visible change without understanding the underlying anatomy tends to produce results that look correct in still photographs and read as overdone in motion.

This page is a longer answer to a question that often arrives in consultation as a single sentence. People ask why their face looks tired, why the area under their eyes has changed, why their cheek no longer sits where it used to, why the jawline has begun to soften. The answer is rarely a single thing.

The skeleton ages, and that matters

Until comparatively recently, facial ageing was discussed almost entirely in terms of skin and soft tissue. Imaging studies over the last twenty years have made clear that the bony skeleton itself remodels measurably across adult life, and the pattern is not symmetrical. The maxilla (the bone that supports the mid face) loses height and projection. The pyriform aperture (the bony rim of the nose) widens. The orbital rim opens superomedially and inferolaterally, which contributes to the deeper appearance of the tear trough. The mandible loses bone in the prejowl region and the gonial angle changes. These are slow, cumulative changes, but they are the structural foundation on which all the soft tissue rests.

This is part of why volume loss in the mid face cannot always be addressed by replacing soft tissue alone. The platform that the soft tissue sits on has changed shape, and an honest assessment names that.

Fat pads, both deep and superficial

Facial fat is not one tissue. It exists in defined compartments, separated by septa, and the compartments behave differently with age. The deep fat pads (the deep medial cheek pad, the buccal pad, the suborbicularis oculi pad) tend to atrophy with age and provide less projection. The superficial pads can also descend and redistribute, contributing to softness in the lower face that did not exist twenty years earlier.

This compartmental anatomy explains why a face can look more tired than gravitationally older. The cheek does not simply fall. The deep pad that supported it has deflated, the superficial pad above it has descended slightly, and the visible result is a flatter mid face with a deeper nasolabial fold and a more shadowed under-eye. The soft tissue is largely still there, just not where it used to be.

Why the under-eye changes the way it does

The infraorbital region is one of the most common reasons people book a consultation for volume loss. The change here involves several mechanisms simultaneously. The orbital rim resorbs, opening the bony socket. The suborbicularis fat pad atrophies. The skin in this region is the thinnest on the face and therefore quickest to show underlying anatomical change. And the orbital fat behind the septum may begin to bulge as the septum weakens, producing the appearance of a herniated pad above the tear trough.

This combination is why under-eye volume change is rarely a one step fix. Some configurations respond to careful filler placement in the deep medial cheek to lift the support of the area indirectly. Some require restraint, because direct under-eye treatment in the wrong anatomy can produce visible product, swelling that does not resolve, or a worsening of the tear trough appearance. The assessment matters more than the treatment.

Cheek volume: structure not stuffing

A cheek that has lost volume looks flat, often with a longer appearing nasolabial fold, a more prominent tear trough above and a softer transition into the lower face below. The instinctive solution (add product to the area that looks empty) is sometimes correct and often is not. Volume placed superficially without addressing the underlying skeletal and deep fat support tends to produce a heavy, distorted appearance that ages poorly.

Anatomy led assessment looks for the pivot points where small amounts of well placed support can lift adjacent tissue, restoring the appearance of the cheek without flooding the region with product. This is one of the central reasons for the slow, conservative dosing approach we use, and one of the most common reasons that we defer treatment in patients who arrive having already received aggressive cheek augmentation elsewhere.

Jawline definition and the prejowl story

The jawline is supported by the bone of the mandible and held in shape by retaining ligaments and the platysma below. With age, the prejowl region loses bone, the mandibular ligament weakens, and the platysma may begin to pull downward more strongly than the elevators that support the lower face. The visible result is softening of the jawline, sometimes with a small jowl forming anterior to the masseter.

This is a region where multiple modalities sometimes contribute to a planned outcome over time. Conservative neuromodulator treatment of an overactive platysma can soften the downward pull. Carefully placed support along the jawline can partially restore definition. But honest assessment will sometimes conclude that the change is beyond what conservative injectable treatment can address, and that conversation needs to happen at the start, not after several treatment sessions that did not deliver what the patient was hoping for.

The role of skin, separately and unavoidably

None of the above anatomy explains why skin changes texture, develops fine lines, or loses the reflectivity it had at twenty. Those are dermal and epidermal changes driven by ultraviolet exposure, hormonal change, and time. Volume restoration cannot improve skin quality, and a face with restored volume but unaddressed skin issues will often look better in photographs than in person.

This is one reason a thorough volume loss consultation almost always includes a separate conversation about skin. Some of that is sun protection, daily SPF, and the basic disciplines that reduce future damage. Some is acknowledging that medical grade topical treatment or dermatological care for skin quality is outside our scope but can be the more important part of a long term plan.

Conservative dosing and the case for slow planning

Volume work, when it is appropriate, rewards restraint. The face that arrives in clinic having received small, well placed support over several appointments looks different from the face that received a large volume in a single session, even when the total product used is the same. The reason is simple: the face does not relax into volume the way it relaxes into skin care. Each treatment session is information about how the patient’s anatomy responds, and that information can only be gathered in stages.

This is the case for the structured review interval that defines the C.O.R.E. Method. Consult, organise the assessment, refine in small treatment sessions, evaluate at the next visit. It is slower than single session volume restoration. It produces results that age more naturally because the face is never asked to absorb a sudden change in support.

What we do not claim

Three claims commonly made about volume restoration do not survive clinical scrutiny and we do not make them. The first is that filler restores a face to how it looked at twenty. It does not. It can soften the visible signs of certain volume changes, sometimes substantially. It does not turn back the underlying clock. The second is that filler is a permanent solution. Hyaluronic based volume products are gradually metabolised over twelve to twenty four months and require maintenance. The third is that filler is without risk. It carries a small but real set of complications, including vascular events, that are managed by careful technique and adequate practitioner training, and that any consultation should explicitly discuss.

Vascular safety and why it shapes our approach

Volume work near defined facial vasculature carries a small but well described risk of vascular compromise. The relevant vessels (facial artery, infraorbital artery, supratrochlear artery, and their branches) sit in predictable but not always identical anatomical positions. Practitioner familiarity with these regions, slow injection technique, careful aspiration and the immediate availability of hyaluronidase for managing any suspected event are the pillars of safe practice.

This is part of the broader case for a one practitioner, low volume, anatomy led model. The clinics where complications are most common are not those that perform the most procedures. They are those that perform procedures most quickly, in highest volume settings, with the lowest practitioner familiarity with the patient in front of them.

How we run the volume loss consultation

The first part of a volume loss consultation is conversation. We want to understand what the patient is seeing, when they began noticing it, what they have read or been told, and what they would consider an over correction. The second part is anatomical assessment in repose and animation, with standardised photography. We discuss the anatomical contributors to what the patient is seeing, the modalities that might address each, and the limits of what conservative injectable treatment can do.

If a treatment plan is appropriate, we discuss it in plain language, including where treatment would be staged across more than one session, the anticipated review interval, and the realistic time to settled appearance. There is no commitment to treatment in the same session. Many patients return for treatment days or weeks after the initial consultation.

AHPRA September 2025 and what this means for volume work

The AHPRA guidelines for nonsurgical cosmetic procedures that came into force in September 2025 require an in person or video consultation with the prescribing practitioner each time a cosmetic injectable is prescribed. Asynchronous prescribing by text or online is no longer acceptable practice. Suitability assessment must explicitly address motivations and expectations.

For volume work in particular, this matters. Volume change is one of the most common reasons people seek injectable treatment, and the gap between what the patient is hoping for and what conservative treatment can deliver is sometimes the most important conversation in the consultation. The September 2025 guidelines effectively codify a standard of care that consultation based practices were already meeting. Practices that were not meeting it have changed how they operate, or are no longer compliant.

What we will not say

Australian regulation prohibits the advertising of Schedule 4 prescription medicines to the public. That includes the brand names, trade names, abbreviations and hashtags associated with cosmetic injectable products. You will not find brand name comparisons or product endorsements anywhere on this site, because the law explicitly prohibits them. We can talk in detail about the class of treatment, the mechanism, the expected response and the clinical considerations. We cannot recommend or promote a specific branded product to the public, and we do not work around that prohibition.

Working with Corey

Corey Anderson is the only practitioner at Core Aesthetics. Registered with the Nursing and Midwifery Board of Australia since January 1996 (AHPRA NMW0001047575), Corey runs a one practitioner, low volume model in Oakleigh. For volume loss work in particular, this matters. Volume planning is rarely a single session decision and benefits from years of continuous record with the same clinician.

Patients see Corey at every visit. Treatment notes carry forward across years. Photographs are standardised and reviewed at every appointment. The model is deliberately at odds with high throughput clinics where the injector rotates and continuity becomes a marketing claim rather than a clinical reality.

The Melbourne south east context

Core Aesthetics operates from 12A Atherton Road, Oakleigh, in Melbourne’s south east. Patients travel from across the south east corridor (Hughesdale, Huntingdale, Chadstone, Clayton, Mount Waverley, Glen Waverley, Wheelers Hill), the bayside strip (Carnegie, Murrumbeena, Bentleigh, McKinnon, Cheltenham), and the inner east. Public transport access via Oakleigh station is straightforward and the clinic offers off street parking.

The geographic detail is mentioned only because volume work is often part of a long planning conversation that benefits from accessibility. Patients who travel an hour each way for treatment tend to space appointments further apart than is ideal. Patients who live within twenty minutes of clinic find structured review more sustainable.

A note on outcomes language

Patients sometimes ask for an estimate of how many years younger they will look after volume restoration. The clinical answer is that ageing is multifactorial and the question itself does not have a single number for an honest answer. What can be said with more accuracy is that softening of specific signs (a particular shadow, a particular fold, a particular asymmetry) tends to read as a refreshed appearance rather than a younger one. People close to the patient often notice that the face looks rested. People meeting the patient for the first time rarely identify the treatment as the cause.

This framing is a deliberate response to the way volume restoration is often marketed elsewhere. Promising a specific younger appearance crosses into territory the regulator explicitly polices, and it sets the patient up for disappointment when the lived reality is more nuanced. The conservative practitioner says less, plans more, and lets the result speak quietly.

Booking a consultation

Volume loss consultations at Core Aesthetics are individually scheduled, with adequate time for conversation and assessment. The consultation is a clinical assessment, not a treatment commitment. If the assessment indicates that treatment is not appropriate today (because the change is beyond conservative injectable scope, because skin issues need addressing first, or because the patient is not yet certain about proceeding), the consultation closes there. That is part of the model, not a deviation from it. Results vary between individuals, and treatment planning is always built around the specific anatomy and goals of the person in front of us.

How Volume Loss Is Distinguished From Skin Laxity At Assessment

Volume loss and skin laxity are clinically distinct findings that often appear together and are commonly conflated in patient self description. Volume loss refers to reduction in the soft tissue scaffolding of the face, primarily the buccal, malar, lateral cheek, and temporal fat compartments and to a lesser extent the deeper structural fat pads. Laxity refers to the loss of elastic recoil in the skin and underlying connective tissue that allows the soft tissue to descend rather than hold position. The two findings respond to different categories of intervention.

The clinical distinction at assessment uses a small set of practical tests. A face that retains its proportions when the patient lies supine but appears hollow or flat when upright is showing volume loss; the supine position recruits gravity dependent tissue back into position. A face that retains its hollow appearance supine is showing structural loss that reflects compartment volume rather than positional descent. A face whose nasolabial fold visibly softens when the cheek is gently lifted with the practitioner’s thumb is showing a fold that is partly created by mid face descent rather than by direct perioral volume change. These bedside tests inform the treatment recommendation more than any imaging would.

The recommendation that follows depends on what the assessment finds. Where volume loss dominates, hyaluronic acid filler placed in the appropriate deep compartments can restore support and reduce the visible consequences of the lost volume. Where laxity dominates, filler placed beneath lax tissue produces visible product without producing the structural change the patient wants, and the appropriate conversation is about whether surgical evaluation would serve the patient better. Where both are present together, the planning conversation is more nuanced, and treatment may be sequenced across appointments rather than executed in a single session.

The consultation is conducted by Corey Anderson, Registered Nurse, AHPRA NMW0001047575. The conversation about volume loss is one of the contexts in which the recommendation against treatment is most likely to be the appropriate clinical conclusion, because the visible problem of advanced laxity is rarely well addressed by any amount of filler and over-treatment in this category produces the heavy, distorted appearance that has become a cultural shorthand for cosmetic injectable failure. The honest assessment is the consultation’s purpose.

Further Reading on Facial Volume

For additional background on the clinical approach to facial volume restoration, see our article: A Guide to Facial Volume Restoration.